These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 30048768)
21. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome. de Martino M; Galli L; Azzari C; Zammarchi E; Vierucci A Vox Sang; 1994; 67(3):317-9. PubMed ID: 7863634 [No Abstract] [Full Text] [Related]
22. Prolonged survival after splenectomy in Wiskott-Aldrich syndrome: a case report. Syrigos KN; Makrilia N; Neidhart J; Moutsos M; Tsimpoukis S; Kiagia M; Saif MW Ital J Pediatr; 2011 Sep; 37():42. PubMed ID: 21906397 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott-Aldrich syndrome. Khoreva A; Abramova I; Deripapa E; Rodina Y; Roppelt A; Pershin D; Larin S; Voronin K; Maschan A; Novichkova G; Shcherbina A Br J Haematol; 2021 Jan; 192(2):366-374. PubMed ID: 33131064 [TBL] [Abstract][Full Text] [Related]
26. One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years. Elfeky RA; Furtado-Silva JM; Chiesa R; Rao K; Amrolia P; Lucchini G; Gilmour K; Adams S; Bibi S; Worth A; Thrasher AJ; Qasim W; Veys P J Allergy Clin Immunol; 2018 Nov; 142(5):1654-1656.e7. PubMed ID: 30055182 [No Abstract] [Full Text] [Related]
27. Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience. Haskoloğlu Ş; Öztürk A; Öztürk G; Kostel Bal S; İslamoğlu C; Baskın K; Ceylaner S; Tufan Satıroğlu L; Doğu F; İkincioğulları A Turk J Haematol; 2020 Nov; 37(4):271-281. PubMed ID: 32812413 [TBL] [Abstract][Full Text] [Related]
28. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome. Mathew P; Conley ME Pediatr Allergy Immunol; 1995 May; 6(2):91-4. PubMed ID: 7581726 [TBL] [Abstract][Full Text] [Related]
29. Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome. Surgical treatment. Faraci RP; Hoffstrand HJ; Witebsky FG; Blaese RM; Beazley RM Arch Surg; 1975 Feb; 110(2):218-20. PubMed ID: 1115623 [TBL] [Abstract][Full Text] [Related]
30. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome. Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369 [TBL] [Abstract][Full Text] [Related]
32. Eltrombopag use in a patient with Wiskott-Aldrich syndrome. Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468 [TBL] [Abstract][Full Text] [Related]
33. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Dupuis-Girod S; Medioni J; Haddad E; Quartier P; Cavazzana-Calvo M; Le Deist F; de Saint Basile G; Delaunay J; Schwarz K; Casanova JL; Blanche S; Fischer A Pediatrics; 2003 May; 111(5 Pt 1):e622-7. PubMed ID: 12728121 [TBL] [Abstract][Full Text] [Related]
34. Splenectomy in the Wiskott-Aldrich syndrome. Nathan DG N Engl J Med; 1980 Apr; 302(16):916-7. PubMed ID: 6767188 [No Abstract] [Full Text] [Related]
35. Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura. Toyoda H; Azuma E; Kawasaki Y; Iwasa T; Ohashi H; Otsuki S; Iwamoto S; Hirayama M; Itoh-Habe N; Wada H; Kondo M; Keida Y; Ito T; Komada Y J Allergy Clin Immunol; 2013 Jul; 132(1):226-7. PubMed ID: 23498591 [No Abstract] [Full Text] [Related]
36. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Corash L; Shafer B; Blaese RM Blood; 1985 Jun; 65(6):1439-43. PubMed ID: 3995178 [TBL] [Abstract][Full Text] [Related]
37. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M; Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656 [TBL] [Abstract][Full Text] [Related]
38. Wiskott Aldrich syndrome: a treatable immune disorder. A review. Millikan LE Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682 [No Abstract] [Full Text] [Related]
39. Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for Wiskott-Aldrich syndrome. Yasuda Y; Yabe H; Inoue H; Shimizu T; Yabe M; Yogo Y; Kato S Pediatr Int; 2008 Apr; 50(2):238-40. PubMed ID: 18353068 [No Abstract] [Full Text] [Related]
40. [Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome]. Wietstruck P MA; Zúñiga C P; Talesnik G E; Méndez R C; Barriga C F Rev Med Chil; 2007 Jul; 135(7):917-23. PubMed ID: 17914550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]